Cargando…

Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder

OBJECTIVE: The Functioning Assessment Short Test (FAST) is a relatively specific test for bipolar disorders designed to assess the main functioning problems experienced by patients. This brief instrument includes 24 items assessing impairment or disability in 6 domains of functioning autonomy, occup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hangoeunbi, Yoon, Bo-Hyun, Bahk, Won-Myong, Woo, Young Sup, Kim, Won, Lee, Jonghun, Sohn, InKi, Park, Sung-Yong, Jon, Duk-In, Jung, Myung Hun, Kim, Moon-Doo, Jung, Young-Eun, Sung, Hyung-Mo, Park, Young-Min, Lee, Jung Goo, Lee, Sang-Yeol, Jang, Seung-Ho, Lim, Eun-Sung, Shim, In Hee, Lee, Kwanghun, Jang, Sae-Heon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889907/ https://www.ncbi.nlm.nih.gov/pubmed/36700325 http://dx.doi.org/10.9758/cpn.2023.21.1.188

Ejemplares similares

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
por: Woo, Young Sup, et al.
Publicado: (2017)

Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study
por: Woo, Young Sup, et al.
Publicado: (2020)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

M185. THE EFFECTS OF GROUP ARTS THERAPY BASED ON EMOTION MANAGEMENT TRAINING ON THE EMOTIONAL EXPRESSION, ALEXITHYMIA, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2020)

Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2023)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

Psychometric Properties of the Hypomania Checklist-32 in Korean Patients with Mood Disorders
por: Yoon, Bo-Hyun, et al.
Publicado: (2017)

T219. THE ROLE OF MELATONIN AND MELATONIN AGONISTS IN COUNTERACTING ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS: A SYSTEMATIC REVIEW
por: Bahk, Won-Myong, et al.
Publicado: (2018)

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA
por: Jang, Seung-Ho, et al.
Publicado: (2020)

Relationship between Handgrip Strength and Low-grade Inflammation in Older Adults with Depression
por: Kang, Kwi Young, et al.
Publicado: (2021)

Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings
por: Jung, Young-Eun, et al.
Publicado: (2019)

Erratum: Lee, J.G., et al. The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease. Brain Sciences 2019, 9(10), 285
por: Lee, Jung Goo, et al.
Publicado: (2019)

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
por: Lee, Jung Goo, et al.
Publicado: (2019)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo, Young Sup, et al.
Publicado: (2015)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Sex Differences in COVID-19 Infection Fear in a Community Sample of Korean Adults Using Quantile Regression
por: Na, Hyunjoo, et al.
Publicado: (2022)

F115. INSIGHT AND MANIC SYMPTOMS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA IN THE KOREAN COMMUNITY
por: Jon, Duk-In, et al.
Publicado: (2018)

COVID-19–Related Functional Impairment in a Community Sample of Korean Adults: Associations With Depression, COVID-19 Infection Fear, and Resilience
por: Park, Yun-ju, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
por: Woo, Young Sup, et al.
Publicado: (2018)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

The Brain–Gut–Microbiome Axis in Psychiatry
por: Jang, Seung-Ho, et al.
Publicado: (2020)

F223. COMPARATIVE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROL
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

S216. CASE REPORT OF TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME IN CHILD ADOLESCENT
por: Doo Kim, Moon, et al.
Publicado: (2020)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

T116. CAFFEINE-INDUCED PSYCHIATRIC MANIFESTATIONS
por: Lee, Kwanghun, et al.
Publicado: (2018)

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
por: Jang, Seung-Ho, et al.
Publicado: (2023)

Psychometric Properties of the Korean Version of the Clinical Language Disorder Rating Scale (CLANG)
por: Park, Seon-Cheol, et al.
Publicado: (2016)

S110. THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5
por: Nam, Beomwoo, et al.
Publicado: (2018)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

Prevalence and Comorbidities of Adult Attention-deficit/ hyperactivity Disorder in a Community Sample from Korea
por: Woo, Young Sup, et al.
Publicado: (2023)

Factors associated with bullying victimization among Korean adolescents
por: Seo, Hye-Jin, et al.
Publicado: (2017)

The prevalence of bipolar spectrum disorder in elderly patients with recurrent depression
por: Lee, Chang-In, et al.
Publicado: (2014)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary
por: Seo, Jeong Seok, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2g8gr6rqfn6shk0vvm4mm95qv